Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.52
-$0.47 (-15.72%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 7.88M | 6.17M | 8.98M | 13.1M | 18.24M | 11.53M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 313.92K | 313.92K | 1.02M | 1.07M | 1.09M | 782.94K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 166.29K | 28K | 603.83K | n/a | 227.04K | n/a |
Total Current Assets | 8.05M | 6.59M | 9.59M | 13.65M | 18.72M | 12.37M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | 27.04K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 313.92K | 313.92K | 1.02M | 1.07M | 1.09M | 809.99K |
Total Assets | 8.36M | 6.9M | 10.61M | 14.72M | 19.82M | 13.18M |
Account Payables | 258.11K | 283.62K | 240.83K | 287.36K | 362.47K | 327.4K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 23.88K | 34.2K | 48.26K | 39.95K | n/a | n/a |
Total Current Liabilities | 968.03K | 894.26K | 809.59K | 1.07M | 1.42M | 936.93K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 27.04K |
Total Liabilities | 968.03K | 894.26K | 809.59K | 1.07M | 1.42M | 963.97K |
Total Debt | n/a | n/a | n/a | n/a | 27.04K | 62.53K |
Book Value | 7.4M | 6.01M | 9.8M | 13.65M | 18.39M | 12.22M |
Book Value Per Share | 4.35 | 3.90 | 6.41 | 9.59 | 17.89 | 19.11 |
Common Stock | 2.29K | 1.55K | 1.54K | 1.52K | 13.47K | 8.77K |
Retained Earnings | -199.88M | -197.19M | -193.23M | -189.1M | -182.55M | -176.9M |
Comprehensive Income | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K | 253.73K |
Shareholders Equity | 7.4M | 6.01M | 9.8M | 13.65M | 18.39M | 12.22M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove XBIO